← Back to MREO

Mereo BioPharma Group plc - American Depositary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Sep 2025Filed 10/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026Sep 2024Filed 10/11/2025Jun 2024Filed 10/11/2025Mar 2024Filed 10/11/2025
$0$0$0$0.5$0$0$0$0
−$7−$6.7−$7−$15−$13−$15−$12−$9
−$0.01−$0.01−$0.01−$0.02−$0.02−$0.02−$0.02−$0.01
804802800799784770770700

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.